Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma

64Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.
Get full text

Abstract

CD47 and thrombospondin 1 and 2 (TSP1 and TSP2) expression were analysed by real-time reverse transcription polymerase chain reaction in fluorescence-activated cell sorted plasma cells (PCs) from patients at consecutive stages of multiple myeloma (MM) development. 80% of MM patients, but only 39% of patients with monoclonal gammopathy of undetermined significance (MGUS) expressed CD47; median expression level increased 10-fold with progression from MGUS to MM. Elevated TSP1/TSP2 levels occurred in bone marrow cultures from MM patients compared with healthy donors. CD47 and TSP1/TSP2 may have a potential role in the pathophysiology of MM, probably in the interaction between MM PCs and the microenvironment. © 2007 The Authors.

Cite

CITATION STYLE

APA

Rendtlew Danielsen, J. M., Knudsen, L. M., Dahl, I. M., Lodahl, M., & Rasmussen, T. (2007). Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma. British Journal of Haematology, 138(6), 756–760. https://doi.org/10.1111/j.1365-2141.2007.06729.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free